Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 1/20 | 0.60 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.57 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.57 |
| ▸ | PTK2 | Q05397 | 4/20 | 0.54 |
| ▸ | CNR2 | P34972 | 3/20 | 0.54 |
| ▸ | ACHE | P22303 | 2/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MGAM | O43451 | 1/20 | 0.49 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | SI | P14410 | 1/20 | 0.49 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8556515 | 0.89 | GRM2 (0.57) | HCAR3GRM2SLC9A1PTK2CNR2 | |
| SCHEMBL16104116 | 0.83 | PTK2 (0.73) | GRM2SLC9A1PTK2ALDH1A1MGAM | |
| SCHEMBL19911537 | 0.83 | ALDH1A1 (0.47) | PTK2PKMALDH1A1MGAMAMY1A | |
| SCHEMBL19911535 | 0.80 | HCAR3 (0.55) | HCAR3SLC9A1PTK2PKMALDH1A1 | |
| SCHEMBL10797939 | 0.79 | HCAR3 (0.68) | HCAR3GRM2SLC9A1PTK2ALDH1A1 | |
| SCHEMBL19911532 | 0.78 | HCAR3 (0.57) | HCAR3SLC9A1CNR2ACHECNR1 | |
| SCHEMBL19911547 | 0.77 | ALDH1A1 (0.44) | HCAR3PTK2PKMALDH1A1MGAM | |
| SCHEMBL3474345 | 0.77 | ALDH1A1 (0.44) | HCAR3PTK2PKMALDH1A1KDM4E | |
| SCHEMBL19911534 | 0.77 | ALDH1A1 (0.44) | PTK2PKMALDH1A1MGAMAMY1A | |
| SCHEMBL19911543 | 0.77 | ALDH1A1 (0.44) | PTK2PKMALDH1A1MGAMAMY1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | HCAR3 4636/4885GRM2 2693/4885SLC9A1 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.